US Stock MarketDetailed Quotes

TKPHF TAKEDA PHARMACEUTICAL CO LTD

Watchlist
  • 26.055
  • +1.015+4.05%
15min DelayClose Apr 26 16:00 ET
40.88BMarket Cap36.04P/E (TTM)

About TAKEDA PHARMACEUTICAL CO LTD Company

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

Company Profile

SymbolTKPHF
Company NameTAKEDA PHARMACEUTICAL CO LTD
Listing DateDec 24, 2018
Founded1781
CEOMr. Christophe Weber
MarketPink Market
Employees49095
Securities TypeOrdinary Shares
Fiscal Year Ends03-31
Address4-1-1 Dosho-machi,Chuo-Ku
CityOsaka
ProvinceOsaka
CountryJapan
Zip Code540-8645
Phone81-6-6204-2111
Websitehttp://www.takeda.co.jp

Company Executives

  • Name
  • Position
  • Salary
  • Christophe Weber
  • Director, President and Chief Executive Officer; Head of Global Business of Takeda Pharmaceuticals U.S.A., Inc.
  • 1.72B
  • Lauren Duprey
  • Chief Human Resources Officer
  • --
  • Takako Ohyabu
  • Chief Global Corporate Affairs and Sustainability Officer
  • --
  • Mwana Lugogo
  • Chief Ethics and Compliance Officer
  • --
  • Gabriele Ricci
  • Chief Data and Technology Officer
  • --
  • Costa Saroukos
  • Director and Chief Financial Officer
  • 2.49B
  • Koki Sato
  • Corporate Strategy Officer
  • --
  • Dr. Thomas Wozniewski, PhD
  • Global Manufacturing and Supply Officer
  • --
  • Marcello Agosti
  • Global Business Development Officer
  • --
  • Teresa Bitetti
  • President, Global Oncology Business Unit
  • --
  • Milano Furuta
  • President, Japan Pharma Business Unit
  • --
  • Giles Platford
  • President, Plasma-Derived Therapies Business Unit
  • --
  • Ramona Sequeira
  • President, Global Portfolio Division
  • --
  • Julie Kim
  • President, U.S. Business Unit and U.S. Country Head
  • --
  • Masami Iijima
  • Chairman of the Board
  • 43.00M
  • Andrew S. Plump, M.D.
  • Director and President, Research and Development
  • 972.00M
  • Yoshiaki Fujimori
  • Independent Director
  • 41.00M
  • Jean-Luc Butel
  • Independent Director
  • 38.00M
  • Olivier Bohuon
  • Independent Director
  • 38.00M
  • Dr. Steven Gillis, Pd.D
  • Independent Director
  • 38.00M
  • Ian T. Clark
  • Independent Director
  • 38.00M
  • Miki Tsusaka
  • Independent Director
  • --
  • Kimberly A. Reed
  • Independent Director
  • 34.00M
  • Emiko Higashi
  • Independent Director
  • 43.00M
  • Dr. John M. Maraganore,PhD
  • Independent Director
  • 32.00M
  • Koji Hatsukawa
  • Independent Director
  • 43.00M
  • Michel Orsinger
  • Independent Director
  • 39.00M
  • Yoshihiro Nakagawa
  • Global General Counsel
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg